Investor Relations

Investor Deck

Stock Price

Analyst Coverage

Small Pharma is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Small Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Small Pharma or its management. Small Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Canaccord Genuity
hc wainwright
Roth Capital Partners

Leading the world’s most advanced DMT clinical program

See how Small Pharma is unlocking the potential of DMT based medicines through ground-breaking and accelerated R&D

Representative example of Small Pharma DMT Molecule

Years of R&D development

patent applications filed

CAD$ raised in 2021

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: